1-hydroxymethylmidazolam has been researched along with ucb 34714 in 1 studies
| Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (ucb 34714) | Trials (ucb 34714) | Recent Studies (post-2010) (ucb 34714) |
|---|---|---|---|---|---|
| 163 | 46 | 49 | 252 | 64 | 224 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheen, AJ; Stockis, A; Watanabe, S | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and ucb 34714
| Article | Year |
|---|---|
Effect of brivaracetam on CYP3A activity, measured by oral midazolam.
Topics: Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Midazolam; Middle Aged; Pyrrolidinones; Young Adult | 2015 |